Session: Dentifrices (AADR Annual Meeting (March 21-24, 2012))

Friday, March 23, 2012: 10:45 a.m.-12:15 p.m.

Session Type: Oral Session
1.5 CE hours

Learning Objectives:
Discuss the effects of dentifrices on the oral cavity

Chairs:

J.C. BUISSON and M. KLUKOWSKA

742

2-Month Gingivitis Treatment Comparison of Stannous Fluoride and Triclosan/Copolymer Dentifrices
M.L. BARKER¹, T. HE¹, A. BIESBROCK¹, M. MINER¹, C. GOYAL², and J. QAQISH², ¹Oral Care Clinical Research, Procter & Gamble Company, Mason, OH, ²Biosci Research America, Inc, Las Vegas, NV

743

Comparative Antiplaque Efficacy of SnF2/Hexametaphosphate and Triclosan Dentifrices
M.A. KLUKOWSKA¹, M.L. BARKER², D.J. WHITE¹, and A.A. BAIG¹, ¹Procter & Gamble Company, Mason, OH, ²Oral Care Clinical Research, Procter & Gamble Company, Mason, OH

744

Dentinal Tubule Occlusion with Stannous Fluoride and KNO₃/Gantrez Dentifrices
M. ZSISKA, M. GIBBS, J.A. MOORE, J.C. BUISSON, and D.J. WHITE, Procter & Gamble Company, Mason, OH

745

Smear Layer Formation and Environmental Stability of Commercial Dentifrices
M. ZSISKA, M. GIBBS, J.A. MOORE, D.J. WHITE, and G. TZEGHAI, Procter & Gamble Company, Mason, OH

746

Superior Anti-gingivitis benefits of Stannous fluoride among triclosan dentifrice users
T. HE¹, M.L. BARKER¹, A. BIESBROCK¹, P. ARMINI², C. GOYAL², and J. QAQISH², ¹The Procter & Gamble Company, Mason, OH, ²BioSci Research America, Inc, Las Vegas, NV

747

Anti-Plaque Benefits of Two Therapeutic Dentifrices Using DPIA
T. HE¹, A. BIESBROCK¹, M.L. BARKER¹, H. EYNON¹, J. MILLEMAN², K. MILLEMAN², M.S. PUTT², and A. WINTERGERST³, ¹The Procter & Gamble Company, Mason, OH, ²University Park Research Center, Fort Wayne, IN, ³Universidad Nacional Autonoma de Mexico, México City DF, Mexico

See more of: Oral Health Research

<< Previous Session | Next Session >>

113 Dentifrices